<p>Versigent (NYSE:VGNT - 获取免费报告) 收到了五家评级公司一致给予的 “买入” 评级，MarketBeat Ratings 报告称。一位分析师对该股票给予了持有建议，三位分析师给予了买入建议，还有一位分析师对该公司给予了强烈买入建议。在过去一年中更新了对该股票覆盖的券商中，12 个月的平均目标价为 38.25 美元。</p>
<p>几位股票分析师对该股票发布了报告。加拿大皇家银行在 3 月 31 日的研究报告中开始覆盖 Versigent 的股票。他们给予了 “行业表现” 评级，并设定了 28.00 美元的目标价。富国银行在 4 月 6 日的研究报告中开始覆盖 Versigent 的股票。他们给予了 “增持” 评级，并设定了 35.00 美元的目标价。Fox Advisors 在 4 月 7 日的研究报告中将 Versigent 的股票升级为 “强烈买入” 评级。华尔街 Zen 在周六的研究报告中将 Versigent 的股票升级为 “持有” 评级。最后，瑞银集团在周二的研究报告中开始覆盖 Versigent 的股票。他们给予了 “买入” 评级，并设定了 43.00 美元的目标价。</p>
<p><strong>查看我们对 Versigent 的最新分析</strong></p>
<h2>Versigent 价格表现</h2>
<p>VGNT 股票在周五开盘价为 34.69 美元。Versigent 的 12 个月低点为 26.34 美元，12 个月高点为 35.08 美元。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们认为比 Versigent 更好的股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVZHTlQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVZHTlQ"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 Versigent 吗？</h2>
<p>在你考虑 Versigent 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Versigent 并不在名单上。</p>
<p>虽然 Versigent 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

VGNT

<p>Versigent (NYSE:VGNT) 收到了五位分析师的共识 “买入” 评级，其中一位持有评级，三位买入评级和一位强烈买入评级。12 个月的平均目标价格为 38.25 美元。最近的分析报告包括加拿大皇家银行的 28.00 美元目标价、富国银行的 35.00 美元目标价和瑞银集团的 43.00 美元目标价。VGNT 股票开盘价为 34.69 美元，12 个月的最低价为 26.34 美元，最高价为 35.08 美元</p>

<p>Versigent (NYSE:VGNT - Get Free Report) has received a consensus rating of &#34;Buy&#34; from the five ratings firms that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation, three have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $38.25.</p>
<div class="lb-trans"><p>Versigent (NYSE:VGNT - 获取免费报告) 收到了五家评级公司一致给予的 “买入” 评级，MarketBeat Ratings 报告称。一位分析师对该股票给予了持有建议，三位分析师给予了买入建议，还有一位分析师对该公司给予了强烈买入建议。在过去一年中更新了对该股票覆盖的券商中，12 个月的平均目标价为 38.25 美元。</p>
</div><p>Several equities analysts have issued reports on the stock. Royal Bank Of Canada assumed coverage on shares of Versigent in a research note on Tuesday, March 31st. They issued a &#34;sector perform&#34; rating and a $28.00 price objective for the company. Wells Fargo &amp; Company assumed coverage on shares of Versigent in a research note on Monday, April 6th. They issued an &#34;overweight&#34; rating and a $35.00 price objective for the company. Fox Advisors upgraded shares of Versigent to a &#34;strong-buy&#34; rating in a research note on Tuesday, April 7th. Wall Street Zen upgraded shares of Versigent to a &#34;hold&#34; rating in a research note on Saturday. Finally, UBS Group assumed coverage on shares of Versigent in a research note on Tuesday. They issued a &#34;buy&#34; rating and a $43.00 price objective for the company.</p>
<div class="lb-trans"><p>几位股票分析师对该股票发布了报告。加拿大皇家银行在 3 月 31 日的研究报告中开始覆盖 Versigent 的股票。他们给予了 “行业表现” 评级，并设定了 28.00 美元的目标价。富国银行在 4 月 6 日的研究报告中开始覆盖 Versigent 的股票。他们给予了 “增持” 评级，并设定了 35.00 美元的目标价。Fox Advisors 在 4 月 7 日的研究报告中将 Versigent 的股票升级为 “强烈买入” 评级。华尔街 Zen 在周六的研究报告中将 Versigent 的股票升级为 “持有” 评级。最后，瑞银集团在周二的研究报告中开始覆盖 Versigent 的股票。他们给予了 “买入” 评级，并设定了 43.00 美元的目标价。</p>
</div><p><strong>Check Out Our Latest Analysis on Versigent</strong></p>
<div class="lb-trans"><p><strong>查看我们对 Versigent 的最新分析</strong></p>
</div><h2>Versigent Price Performance</h2>
<div class="lb-trans"><h2>Versigent 价格表现</h2>
</div><p>Shares of VGNT stock opened at $34.69 on Friday. Versigent has a 12 month low of $26.34 and a 12 month high of $35.08.</p>
<div class="lb-trans"><p>VGNT 股票在周五开盘价为 34.69 美元。Versigent 的 12 个月低点为 26.34 美元，12 个月高点为 35.08 美元。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Versigent</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比 Versigent 更好的股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVZHTlQ" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NYSE&amp;Symbol=VGNT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Versigent Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Versigent 吗？</h2>
</div><p>Before you consider Versigent, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Versigent 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Versigent wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Versigent 并不在名单上。</p>
</div><p>While Versigent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Versigent 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Versigent (NYSE:VGNT) Receives Consensus Recommendation of "Buy" from Analysts

Market Beat

Versigent

加拿大皇家银行

富国银行

瑞银集团

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

Versigent（NYSE 代码：VGNT）获得分析师一致推荐的 “买入” 评级